Veeva Stock Up 0.77% as Vault CRM Counters Salesforce Churn Risks
Veeva shares gained 0.77% amid a 34.84% volume plunge. Vault CRM adoption has mitigated churn risks from Salesforce and other vendors encroaching on large clients.

Created by john smith
Latest Veeva earnings, product updates, and life sciences case studies in one feed
Explore the latest content tracked by Veeva Commercial Pulse
Veeva shares gained 0.77% amid a 34.84% volume plunge. Vault CRM adoption has mitigated churn risks from Salesforce and other vendors encroaching on large clients.
Veeva AI agents transform frontline day-to-day activities in MedTech by automating routine tasks and delivering actionable insights directly to reps.
Veeva PromoMats AI Agents transform MLR reviews for commercial content:
Veeva Systems eyes CRO channel expansion as a strategic move in an environment where industry conditions are somewhat clearer in selected areas, but not enough—key for life sciences commercial pros tracking Veeva's growth.
Salesforce launches Agentforce Contact Center, natively unifying voice, digital channels, CRM data, and AI agents for seamless AI-human handoffs and...
Market vote of confidence in Veeva's Vault CRM migration: Stock jumped 11% post-Q4 FY2026 earnings.
Salesforce escalates rivalry, labeling Veeva purgatory in earnings call.
Investor debate heats up on Veeva's life sciences CRM positioning:
Veeva Systems seeks a Senior Product Manager – New Markets CRM, signaling expansion into new markets while providing software for commercial processes.
The Enterprise Lead SME acts as expert for Pharma Commercial and Digital Marketing domains while defining and owning commercial and digital capabilities roadmaps.
Veeva Consulting is NOW HIRING Veeva Network Consultants for 100% remote roles focused on implementing and supporting clients with Veeva CRM and Veeva Network. Signals expanded capacity for commercial implementations.
Veeva CRM Sandbox and Production orgs will upgrade to the 253.0.600 release for Online platforms, with systems generally available during the process. Plan accordingly for seamless commercial ops.
Veeva demonstrates resilience in life sciences software:
Strong Q3 beat drives optimism for Veeva's trajectory: